Toggle navigation
Home
Search
Services
Blog
Contact
About
Directed Mutagenesis of Htlv-III
Potz, Joseph L.
Dana-Farber Cancer Institute, Boston, MA, United States
Search grants from Joseph Potz
Search grants from Dana-Farber Cancer Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Neuronal Subtype Specific Epigenetic Regulation in Schizophrenia
Variability of mortality levels and trends by state in the United States
Cell Proliferation and the Epidemiology of Breast Cancer
Pulmonary Complications of Htlv-III/Lav - HIV Infection
Immune Mechanisms in Hereditary Interstitial Nephritis
Recently added grants:
Activation Mechanism of Soluble Guanylate Cyclase
Center for Lung Biology and Disease
Atheroprotective Gene Therapy
Mineralocorticoid receptor mediates vascular stiffness via dysregulated immunity in perivascular adipose tissue
Role of LDL receptor family members in protecting the vasculature
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI007502-02
Application #
3029394
Study Section
Clinical Sciences Subcommittee 1 (CLN)
Project Start
1987-04-01
Project End
Budget Start
1987-04-01
Budget End
1987-06-30
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1987
F32 AI
Directed Mutagenesis of Htlv-III
Potz, Joseph L. / Dana-Farber Cancer Institute
NIH 1986
F32 AI
Directed Mutagenesis of Htlv-III
Potz, Joseph L. / Dana-Farber Cancer Institute
Comments
Be the first to comment on Joseph Potz's grant